Related Articles
Quantitative detection of HER2 protein concentration in breast cancer tissue does not increase the number of patients eligible for adjuvant HER2-targeted therapy
Characterization of circulating tumor cells in newly diagnosed breast cancer
Epigenetically altered miR‑193a‑3p promotes HER2 positive breast cancer aggressiveness by targeting GRB7
EGFR/HER2 inhibitors effectively reduce the malignant potential of MDR breast cancer evoked by P-gp substrates in vitro and in vivo
Real-time quantitative RT-PCR detection of circulating tumor cells from breast cancer patients